Outcomes of Window Therapy with Carboplatin and Ifosfamide for Pediatric Osteosarcoma: A Case Series

For the treatment of osteosarcoma, cisplatin (CDDP) can be substituted by carboplatin (CBDCA) to reduce toxicity. We report a single institution experience of CBDCA-based regimen. Two to three cycles of CBDCA + ifosfamide (IFO) therapy (window therapy) were administered as neoadjuvant therapy for os...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiba, Hisaki, Kamei, Michi, Ito, Yasuhiko, Takeda, Risa, Yamada, Satoshi, Okamoto, Hideki, Hayashi, Katsuhiro, Miwa, Shinji, Kawaguchi, Yohei, Saito, Shiro, Sakai, Takao, Murakami, Hideki, Kimura, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136696/
https://www.ncbi.nlm.nih.gov/pubmed/37189985
http://dx.doi.org/10.3390/children10040736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136696/
https://www.ncbi.nlm.nih.gov/pubmed/37189985
http://dx.doi.org/10.3390/children10040736

Ejemplares similares